- Home
- EXP vs HALO Comparison
EXP vs HALO Comparison
Compare EXP & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXP | HALO |
|---|---|---|
| Founded | 1963 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.4B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXP | HALO |
|---|---|---|
| Price | $226.46 | $62.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | ★ $252.22 | $73.33 |
| AVG Volume (30 Days) | 366.2K | ★ 2.4M |
| Earning Date | 01-28-2026 | 11-03-2025 |
| Dividend Yield | ★ 0.44% | N/A |
| EPS Growth | N/A | ★ 56.68 |
| EPS | ★ 13.52 | 4.74 |
| Revenue | ★ $2,301,796,000.00 | $1,242,852,000.00 |
| Revenue This Year | $2.81 | $34.83 |
| Revenue Next Year | $3.96 | $24.84 |
| P/E Ratio | $16.65 | ★ $13.14 |
| Revenue Growth | 1.50 | ★ 31.19 |
| 52 Week Low | $191.91 | $46.26 |
| 52 Week High | $283.00 | $79.50 |
Technical Indicators
Market Signals| Indicator | EXP | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 61.38 | 34.09 |
| Support Level | $216.14 | $61.23 |
| Resistance Level | $229.48 | $63.26 |
| Average True Range (ATR) | 4.98 | 2.42 |
| MACD | 1.55 | -0.79 |
| Stochastic Oscillator | 89.60 | 7.60 |
Price Performance
Historical ComparisonAbout EXP Eagle Materials Inc
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.